• Nie Znaleziono Wyników

Percutaneous closure of “hidden” left atrial appendage with Ultraseal device

N/A
N/A
Protected

Academic year: 2022

Share "Percutaneous closure of “hidden” left atrial appendage with Ultraseal device"

Copied!
2
0
0

Pełen tekst

(1)

Address for correspondence: Prof. Ignacio Cruz-Gonzalez, MD, PhD, University Hospital of Salamanca, Cardiology Department, Paseo San Vicente 58-182, Salamanca, 37007, Spain, tel: +34 923291100, ext. 55369, e-mail: cruzgonzalez.ignacio@gmail.com

Received: 25.03.2019 Accepted: 26.05.2019

Percutaneous closure of “hidden” left atrial appendage with Ultraseal device

Jose Carlos Moreno-Samos, Ignacio Cruz-Gonzalez, Manuel Barreiro-Perez, Monica Fuertes-Barahona, Javier Rodriguez-Collado, Pedro Luis Sanchez-Fernandez

University Hospital of Salamanca, Institute of Biomedical Research in Salamanca (IBSAL), Faculty of Medicine, University of Salamanca, CIBERCV, Salamanca, Spain

A 79-year-old woman with permanent atrial fibrillation under oral anticoagulation was admitted due to recurrent anemia secondary to gastrointesti- nal bleeding. She underwent cardiac surgery 40 years prior, where atrial septal defect was closure and a persistent left-superior vena cava corrected. In 2011, a new open-heart surgery was performed, re- sulting in a bioprosthetic mitral valve, a tricuspid an- nuloplasty and a left atrial appendage (LAA) ligation.

Transesophageal echocardiography (TEE) showed an incomplete LAA closure with an ostium of 12 mm (Fig. 1A, B). After discussion, the heart team decided a percutaneous closure of LAA for interruption of oral anticoagulation.

During the procedure, it was very difficult to locate the LAA ostium despite intracardiac echo- cardiography guidance and left atrium angiograms in different projections (Fig. 1C). Finally, using

TEE guidance and selective injections with an AL1 catheter, the small entrance of the “hidden” LAA was found (Fig. 1D). LAA occlusion was performed with an Ultraseal device (Cardia Inc., Eagan, Min- nesota, USA) (Fig. 1E) achieving a complete LAA sealing (Fig. 1F–I).

The patient had an uneventful recovery and remained asymptomatic after 1-year follow-up.

Incomplete LAA closure following surgical ligation occurs in 30–40% of cases and it is associ- ated with an increased risk of thrombus formation/

/thromboembolism.

The Ultraseal device is composed by a distal soft bulb that anchors the device into the LAA and a proximal sail that seals the LAA. An articulating joint allows a high range of movement and conform- ability, making it potentially ideal for complex cases with variable anatomies.

Conflict of interest: None declared INTERVENTIONAL CARDIOLOGY

Cardiology Journal 2019, Vol. 26, No. 4, 410–411

DOI: 10.5603/CJ.2019.0076 Copyright © 2019 Via Medica

ISSN 1897–5593

410 www.cardiologyjournal.org

IMAGE IN CARDIOVASCULAR MEDICINE

(2)

Figure 1. A. Two-dimensional transesophageal echocardiography (2D TEE) view showing the incomplete left atrial ap- pendage (LAA) closure (white arrow); B. Three-dimensional transesophageal echocardiography (3D TEE) image show- ing the ostium of the incomplete LAA closure (white arrow); C. Fluoroscopic image: left atrium angiogram using a pig- tail catheter; D. Fluoroscopic image: selective injection with AL1 catheter finding LAA location; E. Fluoroscopic image:

Ultraseal device deployment; F. Fluoroscopic image: final result with complete sealing of LAA; G. 2D TEE view: LAA clo- sure with Ultraseal device (red arrow); H. 3D TEE image: Ultraseal device proximal sail view covering the LAA (red arrow);

I. Computed tomography scan image: Ultraseal device position sealing the LAA (red arrow).

www.cardiologyjournal.org 411

Jose Carlos Moreno-Samos et al., Left atrial appendage closure with Ultraseal

Cytaty

Powiązane dokumenty

Transthoracic echocardiography revealed a preserved left ventricular ejection fraction, mild mitral regur- gitation, moderately enlarged left atrium and no intracardiac

In addition, numerous real ‑life registries have reported favorable outcomes with Watchman, ACP, and Amulet devices in patients at higher bleeding risk and / or

aims This study aimed to assess the effectiveness of surgical closure of the left atrial appendage from the inside during minimally invasive mitral valve surgery.. methods A

A marker was placed at the entrance to the pseudoaneurysm just below the level of the aortic valve and projected at the fusion screen (B). The marker facilitated cannulation

PROTECT AF was the first randomised, clinical trial that demonstrated that left atrial appendage closure (LAAC) with Watchman device was non-inferior to warfarin in

Percutaneous left atrial appendage (LAA) closure is emerging as a preven- tive therapy for patients in AF who suffered from a previous stroke or bleeding (secondary prevention)

The Cardia Ultraseal left atrial appendage (LAA) device consists of proximal disc (to cover the LAA orifice) and a distal atraumatic soft lobe (to secure the device in the

ACP implantation was guided by fluoroscopy and three dimensional transesophageal echocardiography (3-D TEE). Device sizing was based on the largest measured diameter of the